FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to abdominal surgery, and is intended for purulent cholangitis treatment. The method includes draining and flushing of common bile duct with antiseptic agent. Miramistin solution is used as such agent, which is injected into common bile duct 2-3 times a day during 3-10 days.
EFFECT: invention enables to avoid adverse cytotoxic effect on tissues of hepatobiliary system, improve efficiency of local antibiotic treatment of cholangitis, including due to increased sensitivity of cholangitis germs to endogenous antimicrobial peptide protein.
2 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTCS OF PURULENT CHOLANGITIS METHOD | 2009 |
|
RU2392624C1 |
| METHOD FOR PREDICTION OF POSTOPERATIVE PYOINFLAMMATORY COMPLICATIONS DEVELOPMENT IN PATIENTS WITH PURULENT CHOLANGITIS | 2009 |
|
RU2399054C1 |
| METHOD OF MODELLING PURULENT OBSTRUCTIVE CHOLANGITIS | 2010 |
|
RU2434307C1 |
| METHOD FOR SELECTION OF MICROORGANISMS POSSESSING ENHANCED RESISTANCE TO CATIONIC ANTIBACTERIAL PEPTIDES AND SERUM BLOOD | 2006 |
|
RU2315112C1 |
| METHOD OF MICROORGANISM ANALYSIS FOR PRODUCING INHIBITORS OF ANTIMICROBIAL THROMBOCYTE PROTEIN (β-LYSINE) | 2007 |
|
RU2351654C2 |
| METHOD OF TREATING PURULENT CHOLANGITIS | 2011 |
|
RU2470600C1 |
| METHOD FOR OPISTHORCHIASIS CHOLANGITIS TREATMENT | 1987 |
|
RU2007172C1 |
| METHOD FOR TREATING PURULENT CHOLANGITIS | 2004 |
|
RU2277916C2 |
| METHOD FOR TREATING THE CASES OF PURULENT CHOLANGITIS | 1998 |
|
RU2155610C2 |
| METHOD FOR CURING OBSTRUCTIVE SPREAD PURULENT CHOLANGITIS | 1992 |
|
RU2086184C1 |
